Prevalence and clinical manifestations of male patients with anogenital warts attending a sexually transmitted disease clinic prior HPV vaccine recommendation

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 45, Issue 6, 2015, Pages 1337-1343

  Jiamton, Sukhum ^a   Leeyaphan, Charussri ^a   Maneeprasopchoke, Pitchaya ^a   Omcharoen, Viboon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anogenital warts; Human immunodeficiency virus (HIV); Men who have sex with men (MSM)

Indexed keywords

EID: 84944879722     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brendle SA, Bywaters SM, Christensen ND. Pathogenesis of infection by human papillomavirus. Curr Probl Dermatol 2014; 45: 47-57.
2. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010; 59: 1-110.
3. Centers for Disease Control and Prevention (CDC). Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Weekly Rep 2011; 60: 1705-8.
4. Centers for Disease Control and Prevention (CDC). National profile: 2012 Sexually transmitted diseases surveillance: Other sexually transmitted diseases. Atlanta: CDC, 2014: 40-5
5. De Panfilis G, Melzani G, Mori G, Ghidini A, Graifemberghi S. Relapses after treatment of external genital warts are more frequent in HIV-positive patients than in HIV-negative controls. Sex Trans Dis 2002; 29: 121-5.
6. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005; 23: 1107-22.
7. Jin F, Prestage GP, Kippax SC, et al. Risk factors for genital and anal warts in a prospective cohort of HIV-negative homosexual men: the HIM study. Sex Trans Dis 2007; 34: 488-93.
8. Kreuter A, Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009; 22: 109-14.
9. Llata E, Stenger M, Bernstein K, et al. Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Trans Dis 2014; 41: 89-93.
10. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19: 1407-14.
11. Palefsky JM. Human papillomavirus-related disease in men: not just a women’s issue. J Adolesc Health 2010; 46: S12-9.
12. Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis 2013; 13: 39.
13. Raymakers AJ, Sadatsafavi M, Marra F, Marra CA. Economic and humanistic burden of external genital warts. Pharmacoeconomics 2012; 30: 1-16.
14. Touze A, de Sanjose S, Coursaget P, et al. Prevalence of anti-human papillomavirus type 16, 18, 31, and 58 virus-like particles in women in the general population and in prostitutes. J Clin Microbiol 2001; 39: 4344-8.
15. van der Snoek EM, Niesters HG, Mulder PG, van Doornum GJ, Osterhaus AD, van der Meijden WI. Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Trans Dis 2003; 30: 639-44.